INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 105 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $60,000 | -54.5% | 52,999 | -9.6% | 0.00% | – |
| Q4 2021 | $132,000 | -88.8% | 58,637 | -83.0% | 0.00% | -100.0% |
| Q3 2021 | $1,178,000 | +15.6% | 344,423 | +1.0% | 0.00% | – |
| Q2 2021 | $1,019,000 | -12.1% | 341,127 | -4.9% | 0.00% | -100.0% |
| Q1 2021 | $1,159,000 | – | 358,854 | +289298.4% | 0.00% | – |
| Q1 2018 | $0 | – | 124 | -44.4% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 223 | -100.0% | 0.00% | -100.0% |
| Q3 2017 | $990,000 | +188.6% | 745,668 | +240.2% | 0.00% | – |
| Q2 2017 | $343,000 | -55.4% | 219,196 | -8.2% | 0.00% | -100.0% |
| Q1 2017 | $769,000 | +17.9% | 238,758 | -50.7% | 0.00% | 0.0% |
| Q4 2016 | $652,000 | -28.0% | 483,875 | -16.8% | 0.00% | 0.0% |
| Q3 2016 | $905,000 | +120.7% | 581,435 | +86.7% | 0.00% | – |
| Q2 2016 | $410,000 | -79.4% | 311,353 | -17.8% | 0.00% | -100.0% |
| Q1 2016 | $1,994,000 | -44.5% | 378,769 | -17.4% | 0.00% | 0.0% |
| Q4 2015 | $3,596,000 | +7.9% | 458,526 | +16.2% | 0.00% | -33.3% |
| Q3 2015 | $3,333,000 | -30.5% | 394,738 | -9.9% | 0.00% | 0.0% |
| Q2 2015 | $4,796,000 | -37.9% | 438,221 | -20.6% | 0.00% | -40.0% |
| Q1 2015 | $7,718,000 | +8.4% | 552,201 | +30.9% | 0.01% | +25.0% |
| Q4 2014 | $7,121,000 | +28.3% | 421,767 | +1.9% | 0.00% | +33.3% |
| Q3 2014 | $5,552,000 | +12.8% | 413,958 | +7.1% | 0.00% | 0.0% |
| Q2 2014 | $4,920,000 | -32.3% | 386,390 | -36.9% | 0.00% | -40.0% |
| Q1 2014 | $7,265,000 | -22.6% | 612,092 | -10.1% | 0.01% | -28.6% |
| Q4 2013 | $9,386,000 | +133.1% | 681,160 | +194.7% | 0.01% | +133.3% |
| Q3 2013 | $4,026,000 | – | 231,113 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,100,000 | $14,762,000 | 6.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,882,805 | $52,107,000 | 1.90% |
| Cheyne Capital Management (UK) LLP | 326,821 | $4,388,000 | 1.56% |
| BB BIOTECH AG | 2,320,737 | $31,144,000 | 1.27% |
| Broadfin Capital, LLC | 854,384 | $11,466,000 | 1.20% |
| HealthCor Management, L.P. | 1,162,200 | $15,597,000 | 0.80% |
| Orbimed Advisors | 4,736,900 | $63,569,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 148,000 | $1,986,000 | 0.58% |
| SOUND ENERGY PARTNERS, INC. | 51,000 | $684,000 | 0.53% |
| Rock Springs Capital Management LP | 210,000 | $2,818,000 | 0.44% |